Effects of 3,4-methylenedioxymethamphetamine on locomotor activity
and extracellular dopamine in the nucleus accumbens of Fischer 344 and Lewis rats

Fernandez F, Porras G, Mormede P, Spampinato U, Chaouloff F.
NeuroGenetique and Stress,
INSERM U471-INRA, Institut Francois Magendie,
Rue Camille Saint Saens, 33077,
Bordeaux Cedex, France
Neurosci Lett 2003 Jan 2;335(3):212-6


Previous studies have shown that Fischer 344 (F344) and Lewis (LEW) rats may differ with respect to their behavioural and neurochemical responses to several drugs of abuse, including amphetamines. Herein, we have examined whether such strain differences extend to a ring-substituted amphetamine, namely 3,4-methylenedioxymethamphetamine (MDMA, ecstasy), a recreationally-used drug endowed with euphoric, but also long-term neurotoxic effects. Beside strain differences in baseline locomotor activity (F344>LEW), it was found that the subcutaneous administration of 10 mg/kg, but not 5 mg/kg, MDMA increased locomotor activity in F344 rats only. On the other hand, such a treatment increased to similar extents extracellular dopamine (DA) levels in the nucleus accumbens of F344 and LEW rats, thus suggesting that genetic differences in MDMA locomotor effects are not accounted for by accumbal DA release.

Oxidative stress
MDMA v fenfluramine
Baboons like Ecstasy
Cutaneous vasoconstriction
Ecstasy/MDMA and cannabis
Arginine-vasopressin release
MDMA, loud noise and the heart
MDMA, HIV and antiretroviral agents
Serotonin, noradrenline and dopamine
MDMA/polydrug users in the UK and Italy

and further reading

Future Opioids
BLTC Research
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family